Results 241 to 250 of about 59,378 (311)

Environmental Disclosure Under Mandatory Regulation in EU Listed Companies: An Institutional Analysis

Business Strategy and the Environment, EarlyView.
ABSTRACT This study examines corporate environmental reporting practices among listed companies in the European Union during the period 2018–2022, within the context of the Non‐Financial Reporting Directive (NFRD). To this end, an Environmental Disclosure Index (EDI) is constructed based on qualitative reporting items, and panel‐data models are ...
Rosalva Pinto‐Braga, Pedro Lorca Fernández, Javier de Andrés Suárez   +2 more
wiley   +1 more source

Epigallocatechin Gallate as a State-Dependent Modulator of Amyloid-<i>β</i>: Molecular Simulation-Guided Mechanistic Synthesis for Structure-Based Inhibitor Design. [PDF]

Biomolecules
Ilić BS.
europepmc   +1 more source

Pleiotropic shared heritability quantifies the shared genetic variance of common diseases. [PDF]

Nat Genet
Zhao Y, Strober B, Hou K, Kerner G, Danesh J, Gazal S, Cheng W, Inouye M, Price AL, Jiang X.   +9 more
europepmc   +1 more source

Interpretable QSAR, External PubChem Validation, and Coordination-Aware Docking Enable Tiered Prioritization of Carbonic Anhydrase I Inhibitors. [PDF]

Pharmaceuticals (Basel)
Elsayad AM, Elsayad KA.
europepmc   +1 more source

Construction of China's climate civil public interest litigation system-from the perspective of public health protection and medical assistance. [PDF]

Front Public Health
Chang J, Zeng G, Hu W.
europepmc   +1 more source

Pharmacovigilance Due Diligence in Drug Development: A Practical Playbook for Risk Identification, Compliance Assessment, and Strategic Decision Making. [PDF]

Drug Saf
Youssef A, Hammad TA.
europepmc   +1 more source

Editorial: Psychiatric insights in genetic and chromosomal disorders. [PDF]

Front Psychiatry
Ishiguro H, Kushima I, Capal JK.
europepmc   +1 more source